Search for: "Acorda Therapeutics, Inc. v. Roxane Laboratories, Inc." Results 1 - 6 of 6
Sorted by Relevance | Sort by Date
RSS Subscribe: 20 results | 100 results
Acorda Therapeutics, Inc. v. Roxane Laboratories, Inc. (Fed. Cir. 2018)
12 Sep 2018, 9:47 pm by Patent Docs
By Kevin E. [read post]
Patent Docs - http://www.patentdocs.org/
Does a “Blocking Patent” also Block Objective Indicia of Nonobviousness
9 Apr 2019, 8:03 pm by Dennis Crouch
  Roxane Laboratories, Inc. [read post]
Patently-O - http://patentlyo.com/patent
Supreme Court Long Conference – Patent Law
30 Sep 2019, 9:02 am by Dennis Crouch
  The court is scheduled to consider whether to grant certiorari in a number of important patent cases: Obviousness: Acorda Therapeutics, Inc. v. [read post]
Patently-O - http://patentlyo.com/patent
Supreme Court 2019-2020: Introduction to the Term’s Patent Cases
8 Oct 2019, 9:44 am by Dennis Crouch
Roxane Laboratories, Inc., No. 18-1280 (obviousness and secondary indicia) Hyatt  v. [read post]
Patently-O - http://patentlyo.com/patent
Big news in multiple sclerosis drugs: Acorda loses appeal on patent invalidity
10 Sep 2018, 10:17 am by Lawrence B. Ebert
Roxane was that Acorda lost:Roxane Laboratories, Inc.; Mylan Pharmaceuticals,Inc.; and Teva Pharmaceuticals USA, Inc., have submittedAbbreviated New Drug Applications seeking FDAapproval to market generic versions of Ampyra. [read post]
IPBiz - http://ipbiz.blogspot.com/
Supreme Court End of Term Updates
19 Jun 2019, 6:18 am by Dennis Crouch
Acorda Therapeutics, Inc. v. [read post]
Patently-O - http://patentlyo.com/patent